South African measles outbreak 2009 - 2010 as experienced by a paediatric hospital

South African Medical Journal

Volumn 102, Issue 9, 2012, Pages 760-764

  le Roux, David M ^a   le Roux, Stanzi M ^a   Nuttall, James J ^a   Eley, Brian S ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CLOXACILLIN; GENTAMICIN; IMMUNOGLOBULIN; MEASLES VACCINE; RETINOL;

ARTICLE; CHILD; DEATH; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; GENDER; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEASLES; MORTALITY; PEDIATRIC HOSPITAL; PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SINGLE DRUG DOSE; SOUTH AFRICA;

ADOLESCENT; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; FEMALE; HOSPITALIZATION; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; MEASLES; RETROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 84867470866     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.5984     Document Type: Article

References (18)

1. Moss WJ, Griffin DE. Measles. Lancet 2012;379:153-164.
2. Uzicanin A, Eggers R, Webb E, et al. Impact of the 1996-1997 supplementary measles vaccination campaigns in South Africa. Int J Epidemiol 2002;31:968-976.
3. World Health Organization: Vaccine Preventable Diseases Monitoring System 2011. http://apps.who. int/immunization_monitoring/en/globalsummary/countryprofileresult.cfm 2010 (accessed 15 July 2011).
4. Moodley S. Immunisation coverage: Western Cape: Review of the data January 2001-2004. Cape Town: Provincial Government of the Western Cape, 2004.
5. Corrigall J, Coetzee D, Cameron N. Is the Western Cape at risk of an outbreak of preventable childhood diseases? Lessons from an evaluation of routine immunisation coverage. S Afr Med J 2008;98:41-45.
6. NICD NHLS. Communicable Diseases Surveillance Bulletin 2009;7:15 July 2011.
7. World Health Organization. Measles vaccines: WHO position paper. Wkly Epidemiol Rec 2009;84:349-360.
8. NICD NHLS. Communicable Diseases Communique. December 2010;9.
9. Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ 2010;340:c1626.
10. Cairns KL, Nandy R, Grais RF. Challenges in measuring measles case fatality ratios in settings without vital registration. Emerg Themes Epidemiol 2010;7:4.
11. Garenne M. Sex differences in measles mortality: a world review. Int J Epidemiol 1994;23:632-642.
12. McMorrow ML, Gebremedhin G, van den Heever J, et al. Measles outbreak in South Africa, 2003-2005. S Afr Med J 2009;99:314-319.
13. Moss WJ, Fisher C, Scott S, et al. HIV type 1 infection is a risk factor for mortality in hospitalized Zambian children with measles. Clin Infect Dis 2008;46:523-527.
14. Moss WJ, Cutts F, Griffin DE. Implications of the human immunodeficiency virus epidemic for control and eradication of measles. Clin Infect Dis 1999;29:106-112.
15. Scott P, Moss WJ, Gilani Z, Low N. Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Infect Dis 2011;204 Suppl 1:S164-78.
16. Scott S, Moss WJ, Cousens S, et al. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis 2007;45:1417-1424.
17. American Academy of Pediatrics. Measles. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2009:448.
18. Tod G, Carrara H, Levin M, Todd G. Dermatological manifestations of measles infection in hospitalised paediatric patients observed in the 2009-2011 Western Cape epidemic. S Afr Med J 2012;102:356.